Hospital Service Volume as an Indicator of Treatment Patterns for Colorectal Cancer
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Hospital cancer treatment volume impacts patient care. High-volume centers may overtreat early-stage colon cancer, while low-volume centers may undertreat it, affecting standard treatment patterns.
Area Of Science
- Oncology
- Health Services Research
- Cancer Treatment
Background
- Hospital approaches to cancer care significantly influence patient treatment outcomes.
- The impact of hospital service volume (SV) on treatment patterns across different cancer stages is not well understood.
- This study investigates the link between hospital SV for metastatic colorectal cancer and nonstandard treatments in earlier stages.
Purpose Of The Study
- To determine if hospital service volume (SV) for metastatic colorectal cancer predicts nonstandard treatment patterns in stages I-III colon cancer.
- To analyze the association between hospital-level SV and the likelihood of receiving nonstandard chemotherapy.
- To identify potential disparities in cancer care based on hospital treatment volume.
Main Methods
- Utilized the National Cancer Database (2010-2017) to analyze colon cancer patient data.
- Employed multivariable logistic regression to adjust for clinicopathological characteristics.
- Evaluated the relationship between hospital SV for metastatic colorectal cancer and nonstandard treatment approaches in stages I-III colon cancer patients.
Main Results
- Significant associations were found between hospital SV for metastatic colorectal cancer and chemotherapy overtreatment in stage I-III colon cancer.
- Patients at highest SV hospitals had 1.29 times higher odds of overtreatment compared to lowest SV hospitals.
- Highest SV hospitals showed 0.64 times the odds of undertreatment compared to lowest SV hospitals for stages II-III disease.
Conclusions
- Hospital service volume for metastatic colon cancer is a key indicator of nonstandard treatment patterns in stages I-III.
- High-volume cancer centers are more prone to overtreatment.
- Low-volume centers are associated with a higher likelihood of undertreatment, highlighting care variations.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...
This lesson explores three gastrointestinal imaging techniques: radionuclide testing, colonic transit studies, and virtual colonoscopy.
Radionuclide Testing
Radionuclide testing is a sophisticated medical technique for assessing gastrointestinal motility. It focuses on gastric emptying and colonic transit time. Radioactive markers track the movement of food through the digestive system, providing insights into gastrointestinal disorders.
In gastric emptying studies, a meal's liquid and...
The colon, or large intestine, is the final segment of the digestive system. Its primary functions include absorbing water and vitamins produced by gut bacteria and transforming waste from liquid to solid to form stool. In adults, the large intestine is approximately 5 feet long and consists of four main sections:
Ascending Colon: Rises upward on the right side of the abdomen.
Transverse Colon: Stretches from the ascending colon across the body to the left side.
Descending Colon: Travels...
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...